Arcturus Therapeutics
ARCT
$26.63
Share price
0.30%
Change (1 day)
1.95%
Change (1 year)
P/S ratio for Arcturus Therapeutics (ARCT)
P/S ratio as of April 2024 (TTM): 4.54
According to Arcturus Therapeutics 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 4.54365. At the end of 2023 the company had a P/S ratio of 5.34.
P/S ratio history for Arcturus Therapeutics from 2013 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 5.34 | 144.02% |
| 2022 | 2.19 | -97.23% |
| 2021 | 78.9 | -29.13% |
| 2020 | 111 | 1307.24% |
| 2019 | 7.92 | 156.81% |
| 2018 | 3.08 | -26.43% |
| 2017 | 4.19 | |
| 2016 | N/A | |
| 2015 | N/A | |
| 2014 | N/A | |
| 2013 | N/A |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 Nymox Pharmaceutical NYMX | N/A | N/A | Bahamas |
 NRC Health
NRC | 5.51 | 21.29% | 🇺🇸 USA |